{"title":"mRNA-1273 SARS-CoV-2疫苗接种后的小纤维神经病变。","authors":"James H Bernheimer, Baohan Pan, Bonnie J Gerecke","doi":"10.1097/CND.0000000000000432","DOIUrl":null,"url":null,"abstract":"REFERENCES 1. Allenbach Y, Benveniste O, Stenzel W, et al. Immunemediated necrotizing myopathy: clinical features and pathogenesis. Nat Rev Rheumatol. 2020;16:689–701. 2. Dalakas MC. Inflammatory myopathies: update on diagnosis, pathogenesis and therapies, and COVID19-related implications. Acta Myol. 2020;39:289–301. 3. Wang MY, Zhao R, Gao LJ, et al. SARS-CoV-2: structure, biology, and structure-based therapeutics development. Front Cell Infect Microbiol. 2020;10:587269. 4. Kassardjian CD, Lennon VA, Alfugham NB, et al. Clinical features and treatment outcomes of necrotizing autoimmune myopathy. JAMA Neurol. 2015;72:996–1003. 5. Marotta DA, Zadourian A, Jabaay MJ, et al. Autoantibody-negative immune-mediated necrotizing myopathy responds to early and aggressive treatment: a case report. Cureus. 2020;12:e7827.","PeriodicalId":39645,"journal":{"name":"Journal of Clinical Neuromuscular Disease","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/ad/99/jcnd-24-169.PMC9943741.pdf","citationCount":"1","resultStr":"{\"title\":\"Small-Fiber Neuropathy After Vaccination With mRNA-1273 SARS-CoV-2 Vaccine.\",\"authors\":\"James H Bernheimer, Baohan Pan, Bonnie J Gerecke\",\"doi\":\"10.1097/CND.0000000000000432\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"REFERENCES 1. Allenbach Y, Benveniste O, Stenzel W, et al. Immunemediated necrotizing myopathy: clinical features and pathogenesis. Nat Rev Rheumatol. 2020;16:689–701. 2. Dalakas MC. Inflammatory myopathies: update on diagnosis, pathogenesis and therapies, and COVID19-related implications. Acta Myol. 2020;39:289–301. 3. Wang MY, Zhao R, Gao LJ, et al. SARS-CoV-2: structure, biology, and structure-based therapeutics development. Front Cell Infect Microbiol. 2020;10:587269. 4. Kassardjian CD, Lennon VA, Alfugham NB, et al. Clinical features and treatment outcomes of necrotizing autoimmune myopathy. JAMA Neurol. 2015;72:996–1003. 5. Marotta DA, Zadourian A, Jabaay MJ, et al. Autoantibody-negative immune-mediated necrotizing myopathy responds to early and aggressive treatment: a case report. Cureus. 2020;12:e7827.\",\"PeriodicalId\":39645,\"journal\":{\"name\":\"Journal of Clinical Neuromuscular Disease\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/ad/99/jcnd-24-169.PMC9943741.pdf\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Clinical Neuromuscular Disease\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1097/CND.0000000000000432\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2023/2/16 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q3\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Clinical Neuromuscular Disease","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/CND.0000000000000432","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/2/16 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
Small-Fiber Neuropathy After Vaccination With mRNA-1273 SARS-CoV-2 Vaccine.
REFERENCES 1. Allenbach Y, Benveniste O, Stenzel W, et al. Immunemediated necrotizing myopathy: clinical features and pathogenesis. Nat Rev Rheumatol. 2020;16:689–701. 2. Dalakas MC. Inflammatory myopathies: update on diagnosis, pathogenesis and therapies, and COVID19-related implications. Acta Myol. 2020;39:289–301. 3. Wang MY, Zhao R, Gao LJ, et al. SARS-CoV-2: structure, biology, and structure-based therapeutics development. Front Cell Infect Microbiol. 2020;10:587269. 4. Kassardjian CD, Lennon VA, Alfugham NB, et al. Clinical features and treatment outcomes of necrotizing autoimmune myopathy. JAMA Neurol. 2015;72:996–1003. 5. Marotta DA, Zadourian A, Jabaay MJ, et al. Autoantibody-negative immune-mediated necrotizing myopathy responds to early and aggressive treatment: a case report. Cureus. 2020;12:e7827.
期刊介绍：
Journal of Clinical Neuromuscular Disease provides original articles of interest to physicians who treat patients with neuromuscular diseases, including disorders of the motor neuron, peripheral nerves, neuromuscular junction, muscle, and autonomic nervous system. Each issue highlights the most advanced and successful approaches to diagnosis, functional assessment, surgical intervention, pharmacologic treatment, rehabilitation, and more.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
